WO2019119077A1 - Composition de soins et de protection solaire - Google Patents

Composition de soins et de protection solaire Download PDF

Info

Publication number
WO2019119077A1
WO2019119077A1 PCT/BR2017/050390 BR2017050390W WO2019119077A1 WO 2019119077 A1 WO2019119077 A1 WO 2019119077A1 BR 2017050390 W BR2017050390 W BR 2017050390W WO 2019119077 A1 WO2019119077 A1 WO 2019119077A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
present
sun
derivatives
emulsion
Prior art date
Application number
PCT/BR2017/050390
Other languages
English (en)
Inventor
Ludmila Pons CAMARGO
Marcos BEZERRA
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Priority to PCT/BR2017/050390 priority Critical patent/WO2019119077A1/fr
Priority to BR112020011082-5A priority patent/BR112020011082B1/pt
Publication of WO2019119077A1 publication Critical patent/WO2019119077A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A61K47/6931—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
    • A61K47/6933—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being obtained by reactions only involving carbon to carbon, e.g. poly(meth)acrylate, polystyrene, polyvinylpyrrolidone or polyvinylalcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds

Definitions

  • the present invention is directed to a sun care composition with high SPF, which comprises an association of a specific emulsifying system, one or more structuring semi-crystalline polymers and a UV filter system, the process of manufacturing the composition and its uses.
  • UVA/UVB sunscreen compositions used to accomplish photoprotection, namely, inorganic UV filters and organic UV filters.
  • UVB radiation causes skin reddening and sunburn, tends to damage the skin more superficial epidermal layers. It plays a key role in the development of skin cancer and a contributory role in tanning and photoaging.
  • the UVA radiation is the dominant tanning ray, and we now know that tanning, whether outdoors or in a salon, causes cumulative damage over time. A tan result from injury to the skin's DNA; the skin darkens in an imperfect attempt to prevent further DNA damage. These imperfections, or mutations, can lead to skin cancer.
  • the long UVA radiations are the less energetic UVA radiation and therefore, they were considered as“less dangerous”. But they are numerous in our environment, as they represent more than 75% of UV rays reaching earth. So it is worth studying their skin impact as they will be repeated every day for a long period of time.
  • the UV filters may either protect against UVA radiation (long wave), UVB radiation (shortwave), or both.
  • UVA radiation long wave
  • UVB radiation shortwave
  • SPDF Sun Protection Factor
  • UVA ratings the degree of UV protection afforded by a sunscreen composition is directly related to the amount and type of UV filters contained therein. The higher the amount of UV filters, the greater the degree of UV protection.
  • sunscreen compositions have been proposed to overcome the effects induced by UVA and/or UVB radiation.
  • They generally contain organic or mineral UV-screening agents, which function according to their own chemical nature and according to their own properties by absorption, reflection or scattering of the UV radiation.
  • they generally contain mixtures of liposoluble organic screening agents and/or of water- soluble UV-screening agents combined with metal oxide pigments such as titanium dioxide or zinc oxide.
  • the sunscreen compositions having UVA or UVB or UVA/UVB filter systems commonly used in the sunscreen cosmetic market are generally in the form of oil, an oil-in-water emulsion (stabilized dispersion of an oily phase in an aqueous phase) or a water-in-oil emulsion (stabilized dispersion of an aqueous phase in an oily phase) comprising at least one oily phase comprising solvents and oils.
  • composition that not only protects the keratin fibers from the damages of the sun, but also hydrates and protects the skin against the pollution and loss of water.
  • the inventors succeeded to overcome the problems of the state of the art and surprisingly revealed a stable sun care composition with high SPF, by the specific combination of an emulsifying system, one or more structuring semi crystalline polymers and a UV filter system of the present invention.
  • the present invention is directed to provide a stable sun care composition with high SPF which comprises an association of specific emulsifying system comprising polyglyceryl-6 distearate and jojoba esters and polyglyceryl-3 beeswax and cetyl alcohol; a structuring semi-crystalline polymer selected from one or more poly C10-30 alkyl acrylates and ammonium acryloyldimethyltaurate/ vinylpyrrolidone copolymers; and a UV filter system, the process of manufacturing the composition and its uses.
  • specific emulsifying system comprising polyglyceryl-6 distearate and jojoba esters and polyglyceryl-3 beeswax and cetyl alcohol
  • a structuring semi-crystalline polymer selected from one or more poly C10-30 alkyl acrylates and ammonium acryloyldimethyltaurate/ vinylpyrrolidone copolymers
  • a UV filter system the process of manufacturing the composition and its uses.
  • composition of the present invention presents a high level of UV- protection in order to protect the keratin fibers from the damages of the sun, having properties of hydrating and protecting the skin against the pollution and loss of water.
  • FIG. 1 (a) to (f) are microscopic photographs of the visual aspect of the composition of the present invention and the composition of the state of the art, demonstrating the stability of the emulsions over 1 and 2 months at 45 Q C.
  • FIG. 2 (a) to (c) are microscopic photographs of the visual aspect of the final composition of the present invention, demonstrating the stability of the emulsion over 1 and 2 months, at different temperatures of 4, 25 and 45 Q C.
  • the sun care composition of the present invention comprises:
  • a structuring semi-crystalline polymer selected from one or more poly C10-30 alkyl acrylates and ammonium acryloyldimethyltaurate/ vinylpyrrolidone copolymers;
  • the composition according to the invention provides excellent sensorial performance as well as surprisingly high SPF values associated to a strong stability over the time.
  • the pH of the sun care composition of the invention is preferably within the range of about 6.2 to about 7.5, more preferably, of about 6.5.
  • the density of the sun care composition of the invention is preferably within the range of about 0.9 g/cm 3 to about 1 .1 g/cm 3 , more preferably, of about 1 .0 g/cm 3 .
  • the viscosity of the sun care composition of the invention is preferably within the range of about 1600 mPa.s to about 3300mPa.s and more preferably of about 1800 to about 2300 mPa.s.
  • the sun care composition of the present invention may present a Sun Protection Factor ranging from 30 to 70.
  • the sun care composition of the present invention may present a Sun Protection Factor of 30, 35, 40, 45, 50, 55, 60, 65 and 70.
  • the sun care composition of the present invention may present a Sun Protection Factor of 30.
  • the sun care composition of the present invention may present a Sun Protection Factor of 50.
  • the sun care composition of the present invention may present a Sun Protection Factor of 70.
  • the Sun Protection Factors 30, 50 and 70 means that if one burns in the sun after 10 minutes with no sunscreen, it will take thirty, fifty or seventy times longer to burn equivalently when the product is applied as directed.
  • the sun care composition of the invention is in the form of an oil in water (O/W) emulsion.
  • the sun care composition of the invention can be used as a daily product for the skin.
  • the sun care composition of the present invention presents fine and light sensation on the skin, auto-adaptation to climate and seasons and pleasure upon application.
  • the composition of the invention is for the manufacture of a product for preventing sunburns, hydrating and protecting the skin against the pollution and loss of water.
  • the expression“at least” means one or more and thus includes individual components as well as mixtures/combinations.
  • ranges provided are meant to include every specific range within, and combination of sub ranges between, the given ranges.
  • a range from 1 -5 includes specifically 1 , 2, 3, 4 and 5, as well as sub ranges such as 2-5, 3-5, 2-3, 2-4, 1 -4, etc.
  • All ranges and values disclosed herein are inclusive and combinable. For examples, any value or point described herein that falls within a range described herein can serve as a minimum or maximum value to derive a sub range, etc.
  • the suitable emulsifying system of the present invention is a natural, PEG-free, O/W sensory emulsifier, which adapts to climate and creates active textures, bringing moisturization and pleasure on application.
  • the emulsifying system of the composition of the present invention comprises a mixture of polyglyceryl-6 distearate, Jojoba Esters, Polyglyceryl-3 Beeswax and Cetyl Alcohol.
  • Emulium Mellifera from Gatefosee.
  • the emulsifying system may be present at a concentration of about 1.5% to about 4%, preferably of about 2.0% to about 3.5% and even more preferable between about 2.5 to about 4.0% by weight of the total weight of the composition.
  • the suitable structuring semi-crystalline polymer of the present invention is an associative oil-phase thickener designed to thicken.
  • oil-phase materials including mineral oil, hydrogenated polyisobutylene (HPIB), vegetal oils, oils esters and triglyceride.
  • HPIB hydrogenated polyisobutylene
  • the suitable structuring semi-crystalline polymer of the present invention are poly C10-C30 alkyl acrylate polymers and ammonium acryloyldimethyltaurate/ vinylpyrrolidone copolymer.
  • the semi-crystalline polymers may especially be those containing a - COOH group, resulting from the copolymerization:
  • Such poly C10-C30 alkyl acrylate structuring semi-crystalline polymer of the present invention is commercially available under the tradename Intelimer IPA 13-1 or Interlimer IPA 13-6 (from Air Products).
  • ammonium acryloyldimethyltaurate/ vinylpyrrolidone copolymer structuring semi-crystalline polymer of the present invention is commercially available under the tradename Aristoflex AVC (from Clariant).
  • the structuring semi-crystalline polymer of the present invention have a melting point ranging from 48 °C to 65 Q C.
  • the structuring semi-crystalline polymer may be present at a concentration of about 0.2 to about 3% and preferably of about 0.3% to about 0.7%.
  • Non-limiting suitable UV filter system of the present invention could be as follows:
  • oil-soluble organic sunscreen ingredient means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in an oil phase or which can be dissolved in colloidal form (for example in micellar form) in an oil fatty phase.
  • Non-limiting examples of oil-soluble organic sunscreen ingredients useful in the invention include, for example, cinnamic derivatives; anthranilates; salicylic derivatives; dibenzoylmethane derivatives; camphor derivatives; benzophenone derivatives; diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives, especially those cited in patent US5624663; benzimidazole derivatives; imidazolines; bis-benzoazolyl derivatives as described in patents EP669323 and US2463264; p-aminobenzoic acid (PABA) derivatives; methylene bis(hydroxyphenylbenzotriazole) derivatives as described in applications US5237071 , US5166355, GB2303549, DE19726184 and EP8931 19; benzoxazole derivatives as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844; screening polymers and screening silicones such as
  • cinnamic derviatives examples include, but are not limited to, ethylhexyl methoxycinnamate sold in particular under the trade name“Parsol ® MCX” by DSM Nutritional Products, isopropyl methoxycinnamate, isoamyl methoxycinnamate sold under the trade name“Neo Heliopan ® E 1000” by Symrise, DEA methoxycinnamate, diisopropyl methylcinnamate, glyceryl ethylhexanoate dimethoxycinnamate.
  • ethylhexyl methoxycinnamate sold in particular under the trade name“Parsol ® MCX” by DSM Nutritional Products
  • isopropyl methoxycinnamate isoamyl methoxycinnamate sold under the trade name“Neo Heliopan ® E 1000” by Symrise
  • DEA methoxycinnamate diisoprop
  • dibenzoylmethane derivatives include, but are not limited to, butyl methoxydibenzoylmethane sold especially under the trade name “Parsol ® 1789” by DSM, isopropyl dibenzoylmethane.
  • suitable salicylic derivatives include, but are not limited to, homosalate sold under the name“Eusolex ® HMS” by Rona/EM Industries, ethylhexyl salicylate sold under the name“Neo Heliopan ® OS” by Symrise, dipropylene glycol salicylate sold under the name“DipsalTM” by Scher, TEA salicylate sold under the name“Neo Heliopan ® TS” by Symrise.
  • beta, beta -Diphenylacrylate derivatives examples include, but are not limited to, octocrylene sold in particular under the trade name“Uvinul ® N539” by BASF, etocrylene sold in particular under the trade name“Uvinul ® N35” by BASF.
  • benzophenone derivatives examples include, but are not limited to, benzophenone-1 sold under the trade name “Uvinul ® 400” by BASF, benzophenone-2 sold under the trade name“Uvinul ® D50” by BASF, benzophenone-
  • Suitable benzylidenecamphor derivatives include, but are not limited to, 3-Benzylidene camphor manufactured under the name“MexorylTM SD” by Chimex, 4-methylbenzylidene camphor sold under the name“Eusolex ® 6300” by Merck, polyacrylamidomethyl benzylidene camphor manufactured under the name “MexorylTM SW” by Chimex.
  • Suitable phenylbenzotriazole derivatives include, but are not limited to, drometrizole trisiloxane sold under the name“silatrizole” by Rhodia Chimie, methylene bis-benzotriazolyl tetramethylbutyl-phenol sold in solid form under the trade name“MIXXIM BB/100” by Fairmount Chemical, or in micronized form as an aqueous dispersion under the trade name “Tinosorb ® M” by Ciba Specialty Chemicals.
  • Triazine derivatives examples include, but are not limited to, bis-Ethylhexyloxyphenol methoxyphenyl triazine sold under the trade name “Tinosorb ® S” by BASF, ethylhexyl triazone sold in particular under the trade name “Uvinul ® T150” by BASF, diethylhexyl butamido triazone sold under the trade name “Uvasorb ® FIEB” by Sigma 3V, 2,4,6-tris(dineopentyl 4’-aminobenzalmalonate)-s- triazine, 2,4,6-tris(diisobutyl 4’-aminobenzalmalonate)-S triazine, 2,4-bis(dineopentyl 4'-aminobenzalmalonate)-6-(n-butyl 4'-aminobenzoate)-s-triazine, symmetrical triazine screening agents
  • An example of a suitable anthranilic derivative includes, but is not limited to, menthyl anthranilate sold under the trade name“Neo Fleliopan ® MA” by Symrise.
  • An example of a suitable imidazoline derivative includes, but is not limited to, ethylhexyl dimethoxybenzylidene dioxoimidazoline propionate.
  • Benzalmalonate derivative includes, but is not limited to, polyorganosiloxane containing benzalmalonate functions, for instance polysilicone-15, sold under the trade name “Parsol ® SLX” by DSM Nutritional Products.
  • An examples of a suitable 4,4-diarylbutadiene derivative includes, but is not limited to, 1 -Dicarboxy(2,2’-dimethylpropyl)-4, 4-diphenyl-butadiene.
  • benzoxazole derivative includes, but is not limited to, 2,4-bis[5-(1 -dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2- ethylhexyl)imino-1 ,3,5-triazine sold under the name Uvasorb ® K2A by Sigma 3V, and mixtures thereof.
  • the oil-soluble organic sunscreen ingredient will be chosen from butyl methoxydibenzoylmethane, ethylhexyl salicylate, ethylhexyl triazone, octocrylene, drometrizole trisiloxane, bis-ethylhexyloxyphenol methoxyphenyl triazine, and mixtures thereof.
  • the oil-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 3% to about 25% by weight, preferably in an amount of from about 5% to about 20% by weight, and most preferably about 7% to about 18% by weight, based on the total weight of the composition.
  • The“water-soluble organic sunscreen ingredient” means any organic compound for screening out UV radiation, which can be fully dissolved in molecular form or miscible in a liquid aqueous phase or which can be dissolved in colloidal form (for example in micellar form) in a liquid aqueous phase.
  • Non-limiting examples of water-soluble organic sunscreen ingredients useful in the invention include, for example, terephthalylidene dicamphor sulfonic acid (Ecamsule), phenylbenzimidazole sulfonic acid (Ensulizole), benzophenone-4, aminobenzoic acid (PABA), 4-Bis(polyethoxy)-para-aminobenzoic acid polyethoxyethyl ester (PEG-25 PABA), camphor benzalkonium methosulfate, methylene bis-benzotriazolyl tetramethylbutylphenol (Bisoctrizole), disodium phenyl dibenzimidazole tetrasulfonate (Bisdisulizole disodium), and tris-biphenyl triazine; their derivatives and corresponding salts; naphthalene bisimide derivatives such as those described in European patent application EP1990372 A2, the entire contents of which is hereby incorporated
  • the salts of the compounds that may be used according to the invention are chosen in particular from salts of alkali metals, for example sodium or potassium; salts of alkaline-earth metals, for example calcium, magnesium or strontium; metal salts, for example zinc, aluminium, manganese or copper; salts of ammonium of formula NH4+; quaternary ammonium salts; salts of organic amines, for instance salts of methylamine, dimethylamine, trimethylamine, triethylamine, ethylamine, 2-hydroxyethylamine, bis(2-hydroxyethyl)amine or tris(2- hydroxyethyl)amine; lysine or arginine salts.
  • Salts chosen from sodium, potassium, magnesium, strontium, copper, manganese or zinc salts are preferably used.
  • the sodium salt is prefereably used.
  • the water-soluble organic sunscreen ingredient will be chosen from terephthalylidene dicamphor sulfonic acid, methylene bis-benzotriazolyl tetramethylbutylphenol, and mixtures thereof.
  • the water-soluble organic sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 0.1 % to about 10% by weight, preferably in an amount of from about 0.5% to about 8% by weight, and most preferably about 1 % to about 7% by weight, based on the total weight of the composition.
  • the “silica-coated titanium dioxide sunscreen ingredient” means spherical beads which are formed by encapsulating titanium dioxide particles in silica.
  • Non-limiting examples of silica coated titanium dioxide sunscreen ingredients useful in the invention include, for example, titanium dioxide coated with silica, such as the product“Sunsil Tin50” from Sunjin Chemical known under the INCI name silica (and) titanium dioxide having a composition of silica:titanium dioxide of about 55:45 and having a particle size from about 2 microns to about 7 microns.
  • silica coated titanium dioxide sunscreen ingredients useful in the invention include, for example, titanium dioxide coated with silica, such as the product“Sunsil Tin50” from Sunjin Chemical known under the INCI name silica (and) titanium dioxide having a composition of silica:titanium dioxide of about 55:45 and having a particle size from about 2 microns to about 7 microns.
  • the silica-coated titanium dioxide sunscreen ingredient is preferably present in the composition according to the invention in an amount of from about 1 % to about 10% by weight, preferably in an amount of from about 2% to about 10% by weight, and most preferably about 5% to about 10% by weight, based on the total weight of the composition.
  • the suitable UV filter system of the present invention comprises terephthalylidene dicamphor sulfonic acid, octocrylene and butyl methoxydibenzoylmethane, which are preferably known as MexorylTM SX and UV System, respectively.
  • the concentration of the mixture of sunscreen/UV filters in the system may be between about 5% to about 35%, preferably between about 7% to about 30% and even more preferably between about 10 to about 29% by weight of the total weight of the composition.
  • composition of the invention may further comprise any usual cosmetically acceptable ingredient, which may be chosen especially from such as additional sunscreens, perfume/fragrance, polymers, preserving agents, solvents, actives, surfactants, fat materials, vitamins, fillers and mixtures thereof.
  • Suitable polymers include, but are not limited to, synthetic wax.
  • Non-limiting example of preserving agent which can be used in accordance with the invention include phenoxyethanol.
  • Suitable fillers of the invention could be as examples of oil-absorbing fillers: mica, zea may (corn) starch, magnesium oxide, nylon-12, nylon-66, cellulose, polyethylene, talc, talc (and) methicone, talc (and) dimethicone, perlite, sodium silicate, pumice, ptfe, polymethyl methacrylate, oryza sativa (rice) starch, aluminum starch octenylsuccinate, potato starch modified, alumina, calcium sodium borosilicate, magnesium carbonate, hydrated silica, dimethicone/vinyl dimethicone crosspolymer, sodium carboxylmethyl starch.
  • mica may (corn) starch, magnesium oxide, nylon-12, nylon-66, cellulose, polyethylene, talc, talc (and) methicone, talc (and) dimethicone, perlite, sodium silicate, pumice, ptfe, polymethyl methacrylate,
  • Suitable solvents include, but are not limited to water, alcohols, glycols and polyols such as glycerin, caprylyl glycol, pentylene glycol, propylene glycol, butylene glycol, and mixtures thereof.
  • the solvent is present in a concentration from about 15 to 00% by weight, or from about 20 to about 80% by weight, or from about 30 to about 70% by weight, or from about 35 to about 75% by weight, or preferably from about 40 to about 70% by weight, and more preferably from about 45 to about 65% by weight, including ranges and sub-ranges there between, based on the total weight of the combinations and/or compositions of the present disclosure.
  • Suitable additional actives include, but are not limited to, disodium EDTA, triethanolamine, and mixtures thereof.
  • surfactants may also be used in the compositions of the present invention non limiting examples of surfactants suitable for use are fatty acids, glyceryl esters in addition to glyceryl stearate, alkoxylated fatty alcohols, such as stearic acid, laureth- 12, glyceryl isostearate, disodium stearoyl glutamate and mixtures thereof.
  • exemplary fat or oil materials include, but are not limited to, esters, fatty acids, synthetic oils, and hydrocarbons/paraffins, such as stearyl alcohol, myristic acid, palmitic acid silicones mineral oil, plant/vegetable oils, and mixtures thereof.
  • Non-limiting example of vitamins suitable for the composition of the present invention includes tocopherol.
  • the additional ingredients may represent from 60% to 85%, such as from 60%to 82% or such as from 65 to 80% by weight of the total weight of the composition.
  • a suitable composition of the invention is as Examples 1 and Example 2 is considered the closest prior art, as follows:
  • Example 1 could be as follows:

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La présente invention concerne une composition de soins et de protection solaire à SPF élevé, qui comprend une association d'un système émulsifiant spécifique, d'un ou plusieurs polymères semi-cristallins structurants et d'un système filtre UV, le procédé de fabrication de la composition et ses utilisations.
PCT/BR2017/050390 2017-12-19 2017-12-19 Composition de soins et de protection solaire WO2019119077A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/BR2017/050390 WO2019119077A1 (fr) 2017-12-19 2017-12-19 Composition de soins et de protection solaire
BR112020011082-5A BR112020011082B1 (pt) 2017-12-19 2017-12-19 Composição de proteção solar, uso de uma composição e método para fabricar a composição

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2017/050390 WO2019119077A1 (fr) 2017-12-19 2017-12-19 Composition de soins et de protection solaire

Publications (1)

Publication Number Publication Date
WO2019119077A1 true WO2019119077A1 (fr) 2019-06-27

Family

ID=61005638

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2017/050390 WO2019119077A1 (fr) 2017-12-19 2017-12-19 Composition de soins et de protection solaire

Country Status (2)

Country Link
BR (1) BR112020011082B1 (fr)
WO (1) WO2019119077A1 (fr)

Citations (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463264A (en) 1942-12-23 1949-03-01 Ciba Ltd Derivatives of cyclic amidines and process of making same
US5166355A (en) 1991-02-04 1992-11-24 Fairmount Chemical Co., Inc. Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols]
WO1993004665A1 (fr) 1991-08-29 1993-03-18 L'oreal Composition cosmetique filtrante contenant un polymere filtre liposoluble a structure hydrocarbonee et une silicone filtre
US5237071A (en) 1991-01-22 1993-08-17 Fairmount Chemical Company, Inc. Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols)
EP0669323A1 (fr) 1994-02-24 1995-08-30 Haarmann & Reimer Gmbh Utilisation de benzazolen comme absorbeurs d'UV nouveaux benzazoles et procédé pour les préparation
US5601811A (en) 1994-08-01 1997-02-11 Croda, Inc. Substantive water-soluble cationic UV-absorbing compounds
GB2303549A (en) 1995-07-22 1997-02-26 Ciba Geigy Ag Micronising organic UV absorbers with alkyl polyglucosides
US5624663A (en) 1987-08-28 1997-04-29 L'oreal Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates
EP0832642A2 (fr) 1996-09-13 1998-04-01 3V SIGMA S.p.A Dérivés de benzoxazole et utilisation comme filtres ultraviolet
DE19726184A1 (de) 1997-06-20 1998-12-24 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen in Form von Emulsionen, insbesondere O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen, mit einem Gehalt an lichtschutzwirksamen Benzotriazolderivaten
EP0893119A1 (fr) 1997-07-26 1999-01-27 Ciba SC Holding AG Formulation protectrice contre UV
DE19746654A1 (de) 1997-08-13 1999-02-18 Basf Ag Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
DE19755649A1 (de) 1997-12-15 1999-06-17 Basf Ag Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
EP0967200A1 (fr) 1998-06-26 1999-12-29 Basf Aktiengesellschaft 4,4-Diarylbutadiènes comme filtres UV hydrosolubles et photostables pour préparations cosmétiques et pharmaceutiques
DE19855649A1 (de) 1998-12-03 2000-06-08 Basf Ag Dimere alpha-Alkyl-Styrolderivate als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
EP1008586A1 (fr) 1998-12-11 2000-06-14 Basf Aktiengesellschaft Diarylbutadiènes oligomères
EP1027883A2 (fr) 1999-01-11 2000-08-16 3V SIGMA S.p.A Combinaison des agents antisolaires contre les rayonnements UV-A et UV-B
US6225467B1 (en) 2000-01-21 2001-05-01 Xerox Corporation Electroluminescent (EL) devices
EP1133980A2 (fr) 2000-03-15 2001-09-19 Basf Aktiengesellschaft Utilisation d'une combinaison d'agents photoprotecteurs comprenant en tant que composé essentiel des hydroxybenzophénones aminosubstituées comme filtres UV photostables dans des préparations cosmétiques et pharmaceutiques
EP1133981A2 (fr) 2000-03-15 2001-09-19 Basf Aktiengesellschaft Utilisation des combinaisons des agents de protection solaire contenant 4,4-Diarylbutadienes comme filtres photostabiles contre les rayonnements UV dans des préparations cosmétiques et pharmaceutiques
EP1300137A2 (fr) 2001-10-02 2003-04-09 3V SIGMA S.p.A Combinations d'agents anti-solaires
DE10162844A1 (de) 2001-12-20 2003-07-03 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Bis-Resorcinyltriazinderivaten und Benzoxazol-Derivaten
WO2004006878A1 (fr) 2002-07-10 2004-01-22 Ciba Specialty Chemicals Holding Inc. Derives de merocyanine a usage cosmetique
WO2004085412A2 (fr) 2003-03-24 2004-10-07 Ciba Specialty Chemicals Holding Inc. Derives de triazine symetriques
WO2005058269A1 (fr) 2003-12-17 2005-06-30 Ciba Specialty Chemicals Holding Inc. Derives de la merocyanine a usage cosmetique
WO2006032741A1 (fr) 2004-09-20 2006-03-30 L'oréal Derives silicies de sulfone merocyanine ; compositions photoprotectrices les contenant ; utilisation comme filtre uv
WO2006035000A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Emulsion photoprotectrice a teneur elevee en pigments filtrants, photoprotecteurs
WO2006034991A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Emulsion eau dans l'huile contenant des pigments filtrants de protection solaire anti-uv
WO2006034992A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Emulsion cosmetique de protection solaire contenant des micropigments organiques
WO2006035007A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Preparation cosmetique de protection solaire a base de micropigments
WO2006034982A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Concentre photoprotecteur a micropigments organiques
WO2006034985A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Emulsion huile dans l'eau contenant des pigments filtrants de protection solaire anti-uv inorganiques et du sulfate d'alkyle
US20070196290A1 (en) * 2004-03-03 2007-08-23 Frank Pflucker Uv filters in powder form
EP1990372A2 (fr) 2007-05-09 2008-11-12 Ciba Holding Inc. Filtres UV hydrosolubles
WO2016012515A2 (fr) * 2014-07-22 2016-01-28 L'oreal Émulsions stabilisées avec un polymère de silicone réticulé et un polymère semi-cristallin
WO2016046210A1 (fr) * 2014-09-26 2016-03-31 Dsm Ip Assets B.V. Émulsions huile/eau
US20170275694A1 (en) * 2014-09-26 2017-09-28 Chanel Parfums Beaute Sestrin activators for preventing and/or attenuating skin ageing and/or hydrating the skin and/or for regulating skin pigmentation

Patent Citations (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463264A (en) 1942-12-23 1949-03-01 Ciba Ltd Derivatives of cyclic amidines and process of making same
US5624663A (en) 1987-08-28 1997-04-29 L'oreal Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates
US5237071A (en) 1991-01-22 1993-08-17 Fairmount Chemical Company, Inc. Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols)
US5166355A (en) 1991-02-04 1992-11-24 Fairmount Chemical Co., Inc. Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols]
WO1993004665A1 (fr) 1991-08-29 1993-03-18 L'oreal Composition cosmetique filtrante contenant un polymere filtre liposoluble a structure hydrocarbonee et une silicone filtre
EP0669323A1 (fr) 1994-02-24 1995-08-30 Haarmann & Reimer Gmbh Utilisation de benzazolen comme absorbeurs d'UV nouveaux benzazoles et procédé pour les préparation
US5601811A (en) 1994-08-01 1997-02-11 Croda, Inc. Substantive water-soluble cationic UV-absorbing compounds
GB2303549A (en) 1995-07-22 1997-02-26 Ciba Geigy Ag Micronising organic UV absorbers with alkyl polyglucosides
EP0832642A2 (fr) 1996-09-13 1998-04-01 3V SIGMA S.p.A Dérivés de benzoxazole et utilisation comme filtres ultraviolet
DE19726184A1 (de) 1997-06-20 1998-12-24 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen in Form von Emulsionen, insbesondere O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen, mit einem Gehalt an lichtschutzwirksamen Benzotriazolderivaten
EP0893119A1 (fr) 1997-07-26 1999-01-27 Ciba SC Holding AG Formulation protectrice contre UV
DE19746654A1 (de) 1997-08-13 1999-02-18 Basf Ag Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
DE19755649A1 (de) 1997-12-15 1999-06-17 Basf Ag Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
EP0967200A1 (fr) 1998-06-26 1999-12-29 Basf Aktiengesellschaft 4,4-Diarylbutadiènes comme filtres UV hydrosolubles et photostables pour préparations cosmétiques et pharmaceutiques
DE19855649A1 (de) 1998-12-03 2000-06-08 Basf Ag Dimere alpha-Alkyl-Styrolderivate als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
EP1008586A1 (fr) 1998-12-11 2000-06-14 Basf Aktiengesellschaft Diarylbutadiènes oligomères
EP1027883A2 (fr) 1999-01-11 2000-08-16 3V SIGMA S.p.A Combinaison des agents antisolaires contre les rayonnements UV-A et UV-B
US6225467B1 (en) 2000-01-21 2001-05-01 Xerox Corporation Electroluminescent (EL) devices
EP1133980A2 (fr) 2000-03-15 2001-09-19 Basf Aktiengesellschaft Utilisation d'une combinaison d'agents photoprotecteurs comprenant en tant que composé essentiel des hydroxybenzophénones aminosubstituées comme filtres UV photostables dans des préparations cosmétiques et pharmaceutiques
EP1133981A2 (fr) 2000-03-15 2001-09-19 Basf Aktiengesellschaft Utilisation des combinaisons des agents de protection solaire contenant 4,4-Diarylbutadienes comme filtres photostabiles contre les rayonnements UV dans des préparations cosmétiques et pharmaceutiques
EP1300137A2 (fr) 2001-10-02 2003-04-09 3V SIGMA S.p.A Combinations d'agents anti-solaires
DE10162844A1 (de) 2001-12-20 2003-07-03 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Bis-Resorcinyltriazinderivaten und Benzoxazol-Derivaten
WO2004006878A1 (fr) 2002-07-10 2004-01-22 Ciba Specialty Chemicals Holding Inc. Derives de merocyanine a usage cosmetique
WO2004085412A2 (fr) 2003-03-24 2004-10-07 Ciba Specialty Chemicals Holding Inc. Derives de triazine symetriques
WO2005058269A1 (fr) 2003-12-17 2005-06-30 Ciba Specialty Chemicals Holding Inc. Derives de la merocyanine a usage cosmetique
US20070196290A1 (en) * 2004-03-03 2007-08-23 Frank Pflucker Uv filters in powder form
WO2006032741A1 (fr) 2004-09-20 2006-03-30 L'oréal Derives silicies de sulfone merocyanine ; compositions photoprotectrices les contenant ; utilisation comme filtre uv
WO2006034991A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Emulsion eau dans l'huile contenant des pigments filtrants de protection solaire anti-uv
WO2006034992A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Emulsion cosmetique de protection solaire contenant des micropigments organiques
WO2006035007A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Preparation cosmetique de protection solaire a base de micropigments
WO2006034982A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Concentre photoprotecteur a micropigments organiques
WO2006034985A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Emulsion huile dans l'eau contenant des pigments filtrants de protection solaire anti-uv inorganiques et du sulfate d'alkyle
WO2006035000A1 (fr) 2004-09-27 2006-04-06 Beiersdorf Ag Emulsion photoprotectrice a teneur elevee en pigments filtrants, photoprotecteurs
EP1990372A2 (fr) 2007-05-09 2008-11-12 Ciba Holding Inc. Filtres UV hydrosolubles
WO2016012515A2 (fr) * 2014-07-22 2016-01-28 L'oreal Émulsions stabilisées avec un polymère de silicone réticulé et un polymère semi-cristallin
WO2016046210A1 (fr) * 2014-09-26 2016-03-31 Dsm Ip Assets B.V. Émulsions huile/eau
US20170275694A1 (en) * 2014-09-26 2017-09-28 Chanel Parfums Beaute Sestrin activators for preventing and/or attenuating skin ageing and/or hydrating the skin and/or for regulating skin pigmentation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Gatuline Link n Lift, an active ingredient extracted from Aesculus hippocastanum flowers, and associated cosmetic formulations", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, 16 March 2017 (2017-03-16), XP013174723, ISSN: 1533-0001 *
"Symmetrical Triazine Derivatives", IP.COM JOURNAL, - 20 September 2004 (2004-09-20)
LENNON P: "COSMETIC FORMULATIONS CONTAINING EMULIUM MELLIFERA", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, 8 January 2014 (2014-01-08), XP013160559, ISSN: 1533-0001 *
PAULA LENNON: "New skincare, suncare and make-up formulations containing Emulium Mellifera", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, 25 November 2014 (2014-11-25), XP013165628, ISSN: 1533-0001 *

Also Published As

Publication number Publication date
BR112020011082A2 (pt) 2020-11-17
BR112020011082B1 (pt) 2022-09-20

Similar Documents

Publication Publication Date Title
JP7028971B2 (ja) Ｕｖ遮蔽剤、アクリルコポリマー、及びアクリルアミドメチルプロパンスルホン酸コポリマーを含む組成物
WO2014097972A1 (fr) Compositions cosmétiques photoprotectrices
JP6730331B2 (ja) Ｕｖ遮蔽剤、アニオン性架橋親水性ポリマー、５以下のｈｌｂを有する界面活性剤およびシリコーンコポリマーを含む組成物
WO2020172725A1 (fr) Composition de produit de protection solaire, utilisation d'une composition de produit de protection solaire, utilisation de cire de carnauba liquide et procédé de fabrication d'une composition de produit de protection solaire
EP2945710A1 (fr) Émulsion cosmétique ou dermatologique comprenant une mérocyanine et un système émulsifiant contenant un polymère amphiphile comprenant au moins une unité d'acide 2-acrylamidomethylpropanesulfonique
EP3334401B1 (fr) Composition de protection solaire à haute teneur en filtres uv liposolubles
WO2014111562A1 (fr) Émulsion cosmétique ou dermatologique comprenant une mérocyanine et un système émulsifiant contenant un sel de métal alcalin d'un ester d'acide phosphorique d'un alcool gras
US9649263B2 (en) Sunscreen composition containing high levels of liposoluble UV filters
US20070009453A1 (en) Photoprotective compositions comprising an aqueous phase and a low melting point apolar wax
JP2007023031A (ja) 水性相と低融点の無極性ワックスとを含む光防護用組成物
WO2014111574A1 (fr) Composition cosmétique ou dermatologique comprenant une mérocyanine, un agent anti-uvb organique et un agent anti-uva organique supplémentaire
US20240000677A1 (en) Tinted cosmetic sunscreen composition, use of a tinted cosmetic sunscreen composition, and process for manufacturing a tinted cosmetic sunscreen composition
EP3829533B1 (fr) Composition d'écran solaire, utilisation de la composition d'écran solaire et procédé de fabrication de la composition d'écran solaire
WO2014111567A2 (fr) Composition cosmétique ou dermatologique comprenant une mérocyanine et un agent anti-uva du type 2-hydroxybenzophénone à substitution amino et/ou un agent anti-uva organique hydrophile
JP5792170B2 (ja) 少なくとも１種の親油性２−ヒドロキシベンゾフェノン遮蔽剤及び少なくとも２つのアルキルアミノベンゾエート基で置換されているケイ素ｓ−トリアジンを含む組成物
WO2019119078A1 (fr) Composition de protection solaire
WO2020172726A1 (fr) Composition d'écran solaire anti-acné, procédé de fabrication d'une composition d'écran solaire anti-acné et utilisation d'une composition d'écran solaire anti-acné
WO2019119077A1 (fr) Composition de soins et de protection solaire
EP3200759B1 (fr) Système d'émulsion exempte d'alcool protégeant contre les uv et transparente lors de l'application
US20150064224A1 (en) Use of Certain Water-Insoluble Porous Polymeric Particles in Spherical Form as SPF Boosters
JP2021143203A (ja) ジベンゾイルメタン誘導体、メロシアニン化合物及びジベンゾイルメタン化合物の三重項励起準位エネルギーを受容可能な化合物を含む光防護組成物
WO2020163928A1 (fr) Composition d'écran solaire, utilisation de la composition d'écran solaire et procédé de fabrication de la composition d'écran solaire
WO2019210376A1 (fr) Compositions d'écran solaire
EP4003289A1 (fr) Composition cosmétique, procédé de fabrication de la composition cosmétique et son utilisation
CN114828810A (zh) 防晒化妆品

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17832189

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112020011082

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112020011082

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20200602

122 Ep: pct application non-entry in european phase

Ref document number: 17832189

Country of ref document: EP

Kind code of ref document: A1